Artelo Biosciences, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 2.17 million compared to USD 1.97 million a year ago. Basic loss per share from continuing operations was USD 0.76 compared to USD 0.7 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | 0.00% | +0.38% | -5.00% |
Jul. 15 | Sector Update: Health Care Stocks Edge Lower Late Afternoon | MT |
Jul. 15 | Sector Update: Health Care Stocks Retreat Monday Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.00% | 4.29M | |
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |
- Stock Market
- Equities
- ARTL Stock
- News Artelo Biosciences, Inc.
- Artelo Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023